Junzhao Yin

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Jiangsu Hengrui Medicine (China)(Current)

Junzhao Yin is an author at Jiangsu Hengrui Medicine (China) specializing in topoisomerase i inhibitors, drug-to-antibody ratio optimization, and targeted therapy.

Publications per year

2023–2025

Publications

Abstract LB031: SHR-A1811, a novel anti-HER2 ADC with superior bystander effect, optimal DAR and favorable safety profiles

Ting Zhang, Lingfeng You, Jianyan Xu et al. · Cancer Research · 2023 · 24 citations

Medicine, Oncology, Pharmacology +17

SHR-A1811, a novel anti-HER2 antibody–drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles

Ting Zhang, Jianyan Xu, Junzhao Yin et al. · PLoS ONE · 2025 · 13 citations · Full text

Pharmacy, Oncology, Pharmacology +17

1–2 of 2